A Protein-Conjugate Approach to Develop a Monoclonal Antibody-Based Antigen Detection Test for the Diagnosis of Human Brucellosis

PLoS Neglected Tropical Diseases

Volumn 8, Issue 6, 2014, Pages

  Patra, Kailash P ^a   Saito, Mayuko ^a   Atluri, Vidya L ^b   Rolán, Hortensia G ^b   Young, Briana ^b   Kerrinnes, Tobias ^b   Smits, Henk ^c   Ricaldi, Jessica N ^d   Gotuzzo, Eduardo ^d   Gilman, Robert H ^e,f   Tsolis, Renee M ^b   Vinetz, Joseph M ^a,d,f  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ROYAL TROPICAL INSTITUTE   (Netherlands)

^d INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOCYANIN; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; ANTIGEN DETECTION; ARTICLE; BLOOD CULTURE; BRUCELLA MELITENSIS; BRUCELLOSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; MOUSE; NONHUMAN; NUCLEIC ACID AMPLIFICATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN PURIFICATION; QUANTITATIVE ANALYSIS; QUANTITATIVE ASSAY; RISK ASSESSMENT; SEROLOGY; WESTERN BLOTTING; YERSINIA ENTEROCOLITICA; ADULT; ANIMAL; BAGG ALBINO MOUSE; BLOOD; BRUCELLA ABORTUS; C57BL MOUSE; CHEMISTRY; DIAGNOSTIC USE; HUMAN; ISOLATION AND PURIFICATION; PROCEDURES; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

ADULT; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; BRUCELLOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LIPOPOLYSACCHARIDES; MICE, INBRED BALB C; MICE, INBRED C57BL; SENSITIVITY AND SPECIFICITY;

EID: 84903472675     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002926     Document Type: Article

References (63)

1. Ruiz Castaneda M, (1961) Laboratory diagnosis of brucellosis in man. Bull World Health Organ 24: 73-84.
2. Pappas G, Akritidis N, Bosilkovski M, Tsianos E, (2005) Brucellosis. N Engl J Med 352: 2325-2336.
3. Baddour MM, Alkhalifa DH, (2008) Evaluation of three polymerase chain reaction techniques for detection of Brucella DNA in peripheral human blood. Can J Microbiol 54: 352-357.
4. Bricker BJ, (2002) PCR as a diagnostic tool for brucellosis. Vet Microbiol 90: 435-446.
5. Castano MJ, Solera J, (2009) Chronic brucellosis and persistence of Brucella melitensis DNA. J Clin Microbiol 47: 2084-2089.
6. Debeaumont C, Falconnet PA, Maurin M, (2005) Real-time PCR for detection of Brucella spp. DNA in human serum samples. Eur J Clin Microbiol Infect Dis 24: 842-845.
7. Ilhan Z, Aksakal A, Ekin IH, Gulhan T, Solmaz H, et al. (2008) Comparison of culture and PCR for the detection of Brucella melitensis in blood and lymphoid tissues of serologically positive and negative slaughtered sheep. Lett Appl Microbiol 46: 301-306.
8. Imaoka K, Kimura M, Suzuki M, Kamiyama T, Yamada A, (2007) Simultaneous detection of the genus Brucella by combinatorial PCR. Jpn J Infect Dis 60: 137-139.
9. Leal-Klevezas DS, Lopez-Merino A, Martinez-Soriano JP, (1995) Molecular detection of Brucella spp.: rapid identification of B. abortus biovar I using PCR. Arch Med Res 26: 263-267.
10. Mitka S, Anetakis C, Souliou E, Diza E, Kansouzidou A, (2007) Evaluation of different PCR assays for early detection of acute and relapsing brucellosis in humans in comparison with conventional methods. J Clin Microbiol 45: 1211-1218.
11. Navarro E, Casao MA, Solera J, (2004) Diagnosis of human brucellosis using PCR. Expert Rev Mol Diagn 4: 115-123.
12. Navarro E, Escribano J, Fernandez J, Solera J, (2002) Comparison of three different PCR methods for detection of Brucella spp in human blood samples. FEMS Immunol Med Microbiol 34: 147-151.
13. Navarro E, Segura JC, Castano MJ, Solera J, (2006) Use of real-time quantitative polymerase chain reaction to monitor the evolution of Brucella melitensis DNA load during therapy and post-therapy follow-up in patients with brucellosis. Clin Infect Dis 42: 1266-1273.
14. Al-Shamahy HA, Wright SG, (1998) Enzyme-linked immunosorbent assay for brucella antigen detection in human sera. J Med Microbiol 47: 169-172.
15. Vrioni G, Pappas G, Priavali E, Gartzonika C, Levidiotou S, (2008) An eternal microbe: Brucella DNA load persists for years after clinical cure. Clin Infect Dis 46: e131-136.
16. Maas KS, Mendez M, Zavaleta M, Manrique J, Franco MP, et al. (2007) Evaluation of brucellosis by PCR and persistence after treatment in patients returning to the hospital for follow-up. Am J Trop Med Hyg 76: 698-702.
17. Al Dahouk S, Tomaso H, Nockler K, Neubauer H, Frangoulidis D, (2003) Laboratory-based diagnosis of brucellosis-a review of the literature. Part II: serological tests for brucellosis. Clin Lab 49: 577-589.
18. Diaz R, Casanova A, Ariza J, Moriyon I, (2011) The Rose Bengal Test in human brucellosis: a neglected test for the diagnosis of a neglected disease. PLoS Negl Trop Dis 5: e950.
19. Gomez MC, Nieto JA, Rosa C, Geijo P, Escribano MA, et al. (2008) Evaluation of seven tests for diagnosis of human brucellosis in an area where the disease is endemic. Clin Vaccine Immunol 15: 1031-1033.
20. Ruiz-Mesa JD, Sanchez-Gonzalez J, Reguera JM, Martin L, Lopez-Palmero S, et al. (2005) Rose Bengal test: diagnostic yield and use for the rapid diagnosis of human brucellosis in emergency departments in endemic areas. Clin Microbiol Infect 11: 221-225.
21. Dabdoob WA, Abdulla ZA, (2000) A panel of eight tests in the serodiagnosis and immunological evaluation of acute brucellosis. East Mediterr Health J 6: 304-312.
22. Cannella AP, Lin JC, Liang L, Atluri V, Gotuzzo E, et al. (2012) Serial kinetics of the antibody response against the complete Brucella melitensis ORFeome in focal vertebral brucellosis. J Clin Microbiol 50: 922-926.
23. Liang L, Leng D, Burk C, Nakajima-Sasaki R, Kayala MA, et al. (2010) Large scale immune profiling of infected humans and goats reveals differential recognition of Brucella melitensis antigens. PLoS Negl Trop Dis 4: e673.
24. Liang L, Tan X, Juarez S, Villaverde H, Pablo J, et al. (2011) Systems biology approach predicts antibody signature associated with Brucella melitensis infection in humans. J Proteome Res 10: 4813-4824.
25. Bosilkovski M, Katerina S, Zaklina S, Ivan V, (2009) The role of Brucellacapt test for follow-up patients with brucellosis. Comp Immunol Microbiol Infect Dis 33: 435-42.
26. Mantecon MA, Gutierrez P, del Pilar Zarzosa M, Duenas AI, Solera J, et al. (2006) Utility of an immunocapture-agglutination test and an enzyme-linked immunosorbent assay test against cytosolic proteins from Brucella melitensis B115 in the diagnosis and follow-up of human acute brucellosis. Diagn Microbiol Infect Dis 55: 27-35.
27. Casao MA, Navarro E, Solera J, (2004) Evaluation of Brucellacapt for the diagnosis of human brucellosis. J Infect 49: 102-108.
28. Orduna A, Almaraz A, Prado A, Gutierrez MP, Garcia-Pascual A, et al. (2000) Evaluation of an immunocapture-agglutination test (Brucellacapt) for serodiagnosis of human brucellosis. J Clin Microbiol 38: 4000-4005.
29. Smits HL, Abdoel TH, Solera J, Clavijo E, Diaz R, (2003) Immunochromatographic Brucella-specific immunoglobulin M and G lateral flow assays for rapid serodiagnosis of human brucellosis. Clin Diagn Lab Immunol 10: 1141-1146.
30. Irmak H, Buzgan T, Evirgen O, Akdeniz H, Demiroz AP, et al. (2004) Use of the Brucella IgM and IgG flow assays in the serodiagnosis of human brucellosis in an area endemic for brucellosis. Am J Trop Med Hyg 70: 688-694.
31. Kose S, Smits HL, Abdoel TH, Ozbel Y, (2006) Prevalence of Brucella antibodies in rural and suburban communities in three provinces of Turkey: need for improved diagnosis and prevention. J Infect 53: 308-314.
32. Franco MP, Mulder M, Gilman RH, Smits HL, (2007) Human brucellosis. Lancet Infect Dis 7: 775-786.
33. Lucero NE, Foglia L, Ayala SM, Gall D, Nielsen K, (1999) Competitive enzyme immunoassay for diagnosis of human brucellosis. J Clin Microbiol 37: 3245-3248.
34. Shemesh AA, Yagupsky P, (2011) Limitations of the standard agglutination test for detecting patients with Brucella melitensis bacteremia. Vector Borne Zoonotic Dis 11: 1599-1601.
35. Somily AM, Adam MH, Gad El Rab MO, Morshed MG, Shakoor Z, (2011) Detection of Salmonella typhi agglutinins in sera of patients with other febrile illnesses and healthy individuals. Ann Afr Med 10: 41-44.
36. Gutierrez MP, Bratos MA, Garrote JI, Duenas A, Almaraz A, et al. (2003) Serologic evidence of human infection by Francisella tularensis in the population of Castilla y Leon (Spain) prior to 1997. FEMS Immunol Med Microbiol 35: 165-169.
37. Chart H, Okubadejo OA, Rowe B, (1992) The serological relationship between Escherichia coli O157 and Yersinia enterocolitica O9 using sera from patients with brucellosis. Epidemiol Infect 108: 77-85.
38. Corbel MJ, Stuart FA, Brewer RA, (1984) Observations on serological cross-reactions between smooth Brucella species and organisms of other genera. Dev Biol Stand 56: 341-348.
39. Westerman RB, He Y, Keen JE, Littledike ET, Kwang J, (1997) Production and characterization of monoclonal antibodies specific for the lipopolysaccharide of Escherichia coli O157. J Clin Microbiol 35: 679-684.
40. Baker PJ, Wilson JB, (1965) Hypoferremia in mice and its application to the bioassay of endotoxin. J Bacteriol 90: 903-910.
41. Kittelberger R, Hilbink F, (1993) Sensitive silver-staining detection of bacterial lipopolysaccharides in polyacrylamide gels. J Biochem Biophys Methods 26: 81-86.
42. Karkhanis YD, Zeltner JY, Jackson JJ, Carlo DJ, (1978) A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of Gram-negative bacteria. Anal Biochem 85: 595-601.
43. de StGroth SF, Scheidegger D, (1980) Production of monoclonal antibodies: strategy and tactics. J Immunol Methods 35: 1-21.
44. Harlow E, Lane D (1988) Antibodies: a laboratory manual. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory.
45. Towbin H, Staehelin T, Gordon J, (1992) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 1979. Biotechnology 24: 145-149.
46. Skurnik M, Biedzka-Sarek M, Lubeck PS, Blom T, Bengoechea JA, et al. (2007) Characterization and biological role of the O-polysaccharide gene cluster of Yersinia enterocolitica serotype O:9. J Bacteriol 189: 7244-7253.
47. Alonso-Urmeneta B, Marin C, Aragon V, Blasco JM, Diaz R, et al. (1998) Evaluation of lipopolysaccharides and polysaccharides of different epitopic structures in the indirect enzyme-linked immunosorbent assay for diagnosis of brucellosis in small ruminants and cattle. Clin Diagn Lab Immunol 5: 749-754.
48. Matthias MA, Ricaldi JN, Cespedes M, Diaz MM, Galloway RL, et al. (2008) Human leptospirosis caused by a new, antigenically unique Leptospira associated with a Rattus species reservoir in the Peruvian Amazon. PLoS Negl Trop Dis 2: e213.
49. Kahl-McDonagh MM, Ficht TA, (2006) Evaluation of protection afforded by Brucella abortus and Brucella melitensis unmarked deletion mutants exhibiting different rates of clearance in BALB/c mice. Infect Immun 74: 4048-4057.
50. Lee CJ, Banks SD, Li JP, (1991) Virulence, immunity, and vaccine related to Streptococcus pneumoniae. Crit Rev Microbiol 18: 89-114.
51. Mulholland K, (1999) Strategies for the control of pneumococcal diseases. Vaccine 17Suppl 1: S79-84.
52. Robbins JB, Schneerson R, (1987) Haemophilus influenzae type b: the search for a vaccine. Pediatr Infect Dis J 6: 791-794.
53. Goldblatt D, (1998) Immunisation and the maturation of infant immune responses. Dev Biol Stand 95: 125-132.
54. Barbour ML, (1996) Conjugate vaccines and the carriage of Haemophilus influenzae type b. Emerg Infect Dis 2: 176-182.
55. Dull PM, McIntosh ED, (2012) Meningococcal vaccine development-from glycoconjugates against MenACWY to proteins against MenB-potential for broad protection against meningococcal disease. Vaccine 30Suppl 2: B18-25.
56. Kubler-Kielb J, Majadly F, Biesova Z, Mocca CP, Guo C, et al. (2010) A bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugates. Proc Natl Acad Sci U S A 107: 1172-1177.
57. Vincent AA, Fanning S, Caira FC, Williamson KC, (1999) Immunogenicity of malaria transmission-blocking vaccine candidate, y230.CA14 following crosslinking in the presence of tetanus toxoid. Parasite Immunol 21: 573-581.
58. Roulland S, Suarez F, Hermine O, Nadel B, (2008) Pathophysiological aspects of memory B-cell development. Trends Immunol 29: 25-33.
59. Vizcaino N, Chordi A, Fernandez-Lago L, (1991) Characterization of smooth Brucella lipopolysaccharides and polysaccharides by monoclonal antibodies. Res Microbiol 142: 971-978.
60. Laurent TC, Mertens P, Dierick JF, Letesson JJ, Lambert C, et al. (2004) Functional, molecular and structural characterisation of five anti-Brucella LPS mAb. Mol Immunol 40: 1237-1247.
61. Cloeckaert A, Weynants V, Godfroid J, Verger JM, Grayon M, et al. (1998) O-Polysaccharide epitopic heterogeneity at the surface of Brucella spp. studied by enzyme-linked immunosorbent assay and flow cytometry. Clin Diagn Lab Immunol 5: 862-870.
62. Kittelberger R, Bundesen PG, Cloeckaert A, Greiser-Wilke I, Letesson JJ, (1998) Serological cross-reactivity between Brucella abortus and yersinia enterocolitica 0:9: IV. Evaluation of the M- and C-epitope antibody response for the specific detection of B. abortus infections. Vet Microbiol 60: 45-57.
63. Weynants V, Gilson D, Cloeckaert A, Tibor A, Denoel PA, et al. (1997) Characterization of smooth lipopolysaccharides and O polysaccharides of Brucella species by competition binding assays with monoclonal antibodies. Infect Immun 65: 1939-1943.